Skip to Content

Eflapegrastim-xnst (Rolvedon) for Chemotherapy-Induced Neutropenia

Download PQI pdf 0.24MB

Last Updated: September 19, 2025

By: Syed Zia Khan, PharmD, BCSCP

About this PQI

The purpose of this PQI is to outline key clinical and operational considerations to optimize outcomes for patients receiving Eflapegrastim-xnst (Rolvedon) for the prevention of chemotherapy-induced neutropenia.

How to Use a Positive Quality Intervention (PQI)

Essentially, it’s a tool to improve patient care by sharing best practices in oncology care. Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.

Find a PQI